Sullivan Eric 4
4 · TCR2 THERAPEUTICS INC. · Filed Jun 27, 2022
Insider Transaction Report
Form 4
Sullivan Eric
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-27+250,000→ 250,000 totalExercise: $2.89Exp: 2032-06-27→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on June 27, 2023, with the remainder vesting in thirty-six 36 equal monthly installments thereafter.